What changed from existing technology?
This study measured the thickness of the inner part of the eye's macula using a special imaging technique to create normal ranges for healthy adults.
This is the first study to establish reference intervals for macular ganglion cell complex parameters in a Persian adult population using spectral-domain OCT.
Commercialization signals visible at publication
This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.
Verified evidence · 1
of 491 participants (mean age 40.62 ± 7.35 years; 218 females and 273 males) were included. Thickness-based GCC parameters demonstrated approximately sym
Abstract ↗- 시제품·장치 구현 근거 미확인
- 제조·규모 확장 근거 미확인
- 장기·실사용 검증 근거 미확인
Later patent, company, clinical, and production events are added separately only after verification.
Patent check: Not checked yetCurrent technology stage: Validation stage
See what changed before reading the full paper.
What still needs to be solved?
Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.
What could change if this succeeds?
These reference intervals may help in the early detection of retinal diseases by providing a baseline for normal macular ganglion cell complex parameters in Persian adults.
Keep following this technology
Revisit changes when new papers, patents, company participation, validation, or products appear.